Dominari Holdings Inc. (NASDAQ:DOMH - Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 812,700 shares, a growth of 30.8% from the August 15th total of 621,200 shares. Approximately 11.1% of the company's stock are short sold. Based on an average daily trading volume, of 317,600 shares, the days-to-cover ratio is presently 2.6 days. Based on an average daily trading volume, of 317,600 shares, the days-to-cover ratio is presently 2.6 days. Approximately 11.1% of the company's stock are short sold.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of Dominari from a "sell" rating to a "buy" rating in a research note on Saturday, August 16th.
Get Our Latest Report on Dominari
Institutional Trading of Dominari
A number of large investors have recently made changes to their positions in the stock. PFG Investments LLC bought a new position in Dominari in the first quarter worth about $566,000. Magnus Financial Group LLC purchased a new stake in Dominari in the 2nd quarter worth approximately $136,000. Geode Capital Management LLC raised its stake in shares of Dominari by 2.9% during the 2nd quarter. Geode Capital Management LLC now owns 66,283 shares of the company's stock worth $361,000 after buying an additional 1,866 shares during the period. Connective Capital Management LLC acquired a new position in shares of Dominari during the 2nd quarter worth approximately $1,446,000. Finally, Jane Street Group LLC acquired a new stake in shares of Dominari in the 2nd quarter worth $158,000. 42.48% of the stock is owned by hedge funds and other institutional investors.
Dominari Stock Up 2.5%
NASDAQ DOMH traded up $0.16 on Friday, hitting $6.49. 257,718 shares of the stock were exchanged, compared to its average volume of 232,888. The stock has a fifty day moving average price of $5.81 and a two-hundred day moving average price of $5.22. Dominari has a 52-week low of $0.83 and a 52-week high of $13.58.
Dominari (NASDAQ:DOMH - Get Free Report) last issued its earnings results on Monday, August 11th. The company reported ($1.02) earnings per share (EPS) for the quarter. The company had revenue of $34.10 million for the quarter. Dominari had a negative net margin of 36.01% and a negative return on equity of 94.32%.
Dominari Dividend Announcement
The business also recently announced a special dividend, which will be paid on Friday, September 26th. Stockholders of record on Wednesday, September 3rd will be paid a dividend of $0.22 per share. The ex-dividend date of this dividend is Wednesday, September 3rd.
Dominari Company Profile
(
Get Free Report)
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Articles
Before you consider Dominari, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dominari wasn't on the list.
While Dominari currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.